Ligand Pharmaceuticals Q4 2024 Earnings Call Transcript: Insights from LGND’s Financial Performance Discussion
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) Q4 2024 Earnings Call: Key Highlights On February 27, 2025, Ligand Pharmaceuticals Incorporated held its Fourth Quarter and Full Year 2024 Earnings Call. The call was led by Melanie Herman, Senior Director of Financial Planning and Analysis, Todd Davis, CEO, Paul Hadden, Senior Vice President of Investments and Business Development,…